{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:02:11Z","timestamp":1785535331580,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":709,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Stockholm County Council"},{"name":"the Swedish Childhood Cancer Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Swedish Society for Medical Research, Stockholm County Council"},{"name":"Signe and Olof Wallenius Stiftelse and Stiftelsen Olle Engkvist Byggm\u00e4stare"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbmt.2013.02.015","type":"journal-article","created":{"date-parts":[[2013,2,24]],"date-time":"2013-02-24T13:46:11Z","timestamp":1361713571000},"page":"838-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Chimerism Patterns of Long-Term Stable Mixed Chimeras Posthematopoietic Stem Cell Transplantation in Patients with Nonmalignant Diseases: Follow-Up of Long-Term Stable Mixed Chimerism Patients"],"prefix":"10.1016","volume":"19","author":[{"given":"Arwen","family":"Stikvoort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Sundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.02.015_bib1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.tp.0000181457.43146.36","article-title":"Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single center","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.02.015_bib2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/sj.leu.2404335","article-title":"Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"20","author":"Baron","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.02.015_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bmt.1704715","article-title":"How and when should we monitor chimerism after allogeneic stem cell transplantation?","volume":"35","author":"Bader","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2009.82","article-title":"Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism","volume":"44","author":"Svenberg","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007890-198711000-00010","article-title":"Lymphoid chimerism after allogeneic bone marrow transplantation. Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulins","volume":"44","author":"Korver","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.02.015_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.transci.2004.10.006","article-title":"Hemopoietic chimerism following stem cell transplantation","volume":"32","author":"McCann","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bbmt.2013.02.015_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2141.2001.03174.x","article-title":"Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation","volume":"115","author":"Mattsson","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.02.015_bib8","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2169\/internalmedicine.46.0249","article-title":"Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia","volume":"46","author":"Saito","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.bbmt.2013.02.015_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0609.2005.00538.x","article-title":"Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia","volume":"75","author":"Mao","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2013.02.015_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.leu.2402343","article-title":"Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation","volume":"16","author":"Schaap","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.02.015_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12185-009-0398-y","article-title":"Stable mixed donor-donor chimerism after double cord blood transplantation","volume":"90","author":"Berglund","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2013.02.015_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.2010.04212.x","article-title":"Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation","volume":"162","author":"Gertow","year":"2010","journal-title":"Clin Ex Immunol"},{"key":"10.1016\/j.bbmt.2013.02.015_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.leu.2401669","article-title":"Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease","volume":"14","author":"Mattsson","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.02.015_bib14","first-page":"150","article-title":"Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation","volume":"2","author":"Winiarski","year":"1998","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib15","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1182\/blood.V99.12.4618","article-title":"Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction","volume":"99","author":"Alizadeh","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.02.015_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","article-title":"Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation","volume":"24","author":"Remberger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib17","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","article-title":"Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care","volume":"100","author":"Svahn","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.02.015_bib18","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings","volume":"15","author":"Ringden","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","article-title":"Cyclosporine v methotrexate for graft-v-host disease prevention in patient given marrow grafts for leukemia: long-term follow-up of three controlled trials","volume":"71","author":"Storb","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.02.015_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"New Eng J Med"},{"key":"10.1016\/j.bbmt.2013.02.015_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation","volume":"78","author":"Remberger","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.02.015_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bmt.2008.239","article-title":"Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor","volume":"42","author":"Ringden","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/14653241003709678","article-title":"Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to?","volume":"12","author":"Turner","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2013.02.015_bib24","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.02.015_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2141.2008.07533.x","volume":"144","author":"Lawler","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.02.015_bib26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bbmt.2011.07.008","article-title":"Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies","volume":"17","author":"Passweg","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V67.3.811.811","article-title":"Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease","volume":"67","author":"Hill","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.02.015_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1651-2227.2011.02494.x","article-title":"The developing immune system - from foetus to toddler","volume":"101","author":"Ygberg","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.bbmt.2013.02.015_bib29","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1097\/01.TP.0000067947.90241.66","article-title":"Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance","volume":"75","author":"Wekerle","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.02.015_bib30","first-page":"767","article-title":"Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia","volume":"18","author":"Huss","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbmt.2009.03.018","article-title":"Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants","volume":"15","author":"Spellman","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bmt.1704154","article-title":"Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation","volume":"32","author":"Mattsson","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.02.015_bib33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.tp.0000235889.05171.12","article-title":"Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation","volume":"82","author":"Subklewe","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.02.015_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2010.112","article-title":"Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated","volume":"46","author":"Poutsiaka","year":"2011","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.bbmt.2013.02.015_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2011-12-401166","article-title":"Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins","volume":"120","author":"Eriguchi","year":"2012","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:45:18Z","timestamp":1761057918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1083879113001006"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.02.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimerism Patterns of Long-Term Stable Mixed Chimeras Posthematopoietic Stem Cell Transplantation in Patients with Nonmalignant Diseases: Follow-Up of Long-Term Stable Mixed Chimerism Patients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}